loader2
Partner With Us NRI

Company details

110.20
113.85
96.00
227.95
6M Return -31.94%
1Y Return -13.85%
Mkt Cap.(Cr) 239.33
Volume 2,441
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 2,441

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: -12.73 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 2,384.58 25,141.00
LAST 3M 44,802.10 -11,969.10
LAST 6M 126,363.03 -152,810.52
LAST 12M 215,488.67 -221,056.82
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
No data found

Information

  • About Company
  • Company Info
  • Listing Info
0
72.74%
-34.8272
0%
0%
Description
  • Krebs Biochemicals & Industries Ltd[KBIL](Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. KBIL since inception, has adopted global agenda for its growth by focusing on its specific area of expetise `Fermentation Technology`. During 2001-02, the company has successfully launched Vitamin C(I P Grade) through Fermentation Process.The company has also received ISO 9002 Certification for Unit I at Nellore from Yarsley International Certifications Services accredited by United Kingdom Accreditation Services. The company is now producing and marketing Lovastatin,Simvastatin and Vitamin-C. The company is now in the process of installing a co-generation power plant at Unit-II. As a step in the direction of backward integration and to capitalise on co-generation and Ethanol manufacturing the company has successfully bidded and acquired the Nannapaneni Venkatrao Co-operative Sugars Ltd located at Jampani in Guntur District of Andhra Pradesh from the Andhra Pradesh Government in Dec 28, 2003.

Read More

Registered Address

Kothapalli(V) Kasimkota(M), Anakapalli, Vishakapatnam, Andhra Pradesh, 531031

Tel : 91-040-6680 8040
Email : investors:kerbsbiochem.com
Website : http://www.krebsbiochem.com

Registrar

Satguru Management Consultants

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524518
NSE Code : KREBSBIO
Book Closure Date (Month) :
BSE Group : B
ISIN : INE268B01013

ICICIdirect Krebs Biochemicals & Industries Ltd FAQ

You can buy Krebs Biochemicals & Industries Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Krebs Biochemicals & Industries Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Aug 10, 2022 04:01 PM the closing price of Krebs Biochemicals & Industries Ltd was ₹ 111.00.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Aug 10, 2022 04:01 PM, the market cap of Krebs Biochemicals & Industries Ltd stood at ₹ 239.33.
The latest PE ratio of Krebs Biochemicals & Industries Ltd as of Aug 10, 2022 04:01 PM is 0
The latest PB ratio of Krebs Biochemicals & Industries Ltd as of Aug 10, 2022 04:01 PM is -0.31
The 52-week high of Krebs Biochemicals & Industries Ltd is ₹ 227.95 while the 52-week low is ₹ 96.00 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE